1:Pegylated Interferon- a2b, PEG-IFN-a2b

2 trials

Sponsors

The First Affiliated Hospital, College of Medicine, Zhejiang University

Conditions

Chronic (viral) hepatitis B

Unknown Phase

Increase the Clinical Cure Rate with Immunomodulatory/ Antiviral based Combination Therapy in HBeAg Positive Chronic Hepatitis B Patients

RecruitingChiCTR1800016173

The First Affiliated Hospital, College of Medicine, Zhejiang UniversityChronic (viral) hepatitis B

Start: 2018-06-01Updated: 2018-05-21

Increase the Clinical Cure Rate with Immunomodulatory/ Antiviral based Combination Therapy in HBeAg Negative Chronic Hepatitis B Patients

RecruitingChiCTR1800016170

The First Affiliated Hospital, College of Medicine, Zhejiang UniversityChronic (viral) hepatitis B

Start: 2018-06-01Updated: 2018-05-21

Related Papers

Pegylated interferon‐α‐2b combined with tenofovir disoproxil fumarate, granulocyte‐macrophage colony‐stimulating factor, and hepatitis B vaccine treatment for naïve HBeAg‐positive chronic hepatitis B patients: A prospective, multicenter, randomized controlled study

Journal of Medical Virology2022-07-158 citations